Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 248 entries
Sorted by: Best Match Show Resources per page
Impact on CO₂/N₂ and CO₂/CH₄ Separation Performance Using Cu-BTC with Supported Ionic Liquids-Based Mixed Matrix Membranes.

Membranes

Monteiro B, Nabais AR, Casimiro MH, Martins APS, Francisco RO, Neves LA, Pereira CCL.
PMID: 30314326
Membranes (Basel). 2018 Oct 11;8(4). doi: 10.3390/membranes8040093.

The efficient separation of gases has industrial, economic, and environmental importance. Here, we report the improvement in gas separation performance of a polyimide-based matrix (Matrimid

Cite
Monteiro B, Nabais AR, Casimiro MH, et al. Impact on CO₂/N₂ and CO₂/CH₄ Separation Performance Using Cu-BTC with Supported Ionic Liquids-Based Mixed Matrix Membranes. Membranes (Basel). 2018;8(4)doi: 10.3390/membranes8040093.
Monteiro, B., Nabais, A. R., Casimiro, M. H., Martins, A. P. S., Francisco, R. O., Neves, L. A., & Pereira, C. C. L. (2018). Impact on CO₂/N₂ and CO₂/CH₄ Separation Performance Using Cu-BTC with Supported Ionic Liquids-Based Mixed Matrix Membranes. Membranes, 8(4), . https://doi.org/10.3390/membranes8040093
Monteiro, Bernardo, et al. "Impact on CO₂/N₂ and CO₂/CH₄ Separation Performance Using Cu-BTC with Supported Ionic Liquids-Based Mixed Matrix Membranes." Membranes vol. 8,4 (2018). doi: https://doi.org/10.3390/membranes8040093
Monteiro B, Nabais AR, Casimiro MH, Martins APS, Francisco RO, Neves LA, Pereira CCL. Impact on CO₂/N₂ and CO₂/CH₄ Separation Performance Using Cu-BTC with Supported Ionic Liquids-Based Mixed Matrix Membranes. Membranes (Basel). 2018 Oct 11;8(4). doi: 10.3390/membranes8040093. PMID: 30314326; PMCID: PMC6316195.
Copy Download .nbib Format: NLM
Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015.

PloS one

Cegolon L, Campbell O, Alberico S, Montico M, Mastrangelo G, Monasta L, Ronfani L, Barbone F.
PMID: 30840695
PLoS One. 2019 Mar 06;14(3):e0213664. doi: 10.1371/journal.pone.0213664. eCollection 2019.

[This corrects the article DOI: 10.1371/journal.pone.0204919.].

Cite
Cegolon L, Campbell O, Alberico S, et al. Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015. PLoS One. 2019;14(3):e0213664doi: 10.1371/journal.pone.0213664.
Cegolon, L., Campbell, O., Alberico, S., Montico, M., Mastrangelo, G., Monasta, L., Ronfani, L., & Barbone, F. (2019). Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015. PloS one, 14(3), e0213664. https://doi.org/10.1371/journal.pone.0213664
Cegolon, Luca, et al. "Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015." PloS one vol. 14,3 (2019): e0213664. doi: https://doi.org/10.1371/journal.pone.0213664
Cegolon L, Campbell O, Alberico S, Montico M, Mastrangelo G, Monasta L, Ronfani L, Barbone F. Correction: Length of stay following vaginal deliveries: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015. PLoS One. 2019 Mar 06;14(3):e0213664. doi: 10.1371/journal.pone.0213664. eCollection 2019. PMID: 30840695; PMCID: PMC6402662.
Copy Download .nbib Format: NLM
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.

Journal of medicinal chemistry

Nozal V, Martínez-González L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, Pérez-Cuevas E, Knapp S, Lietha D, Ramírez D, Petralla S, Monti B, Gil C, Martín-Requero A, Palomo V, de Lago E, Martinez A.
PMID: 34978799
J Med Chem. 2022 Jan 03; doi: 10.1021/acs.jmedchem.1c01942. Epub 2022 Jan 03.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease without any effective treatment. Protein TDP-43 is a pathological hallmark of ALS in both sporadic and familiar patients. Post-translational modifications of TDP-43 promote its aggregation in the cytoplasm. Tau-Tubulin kinase...

Cite
Nozal V, Martínez-González L, Gomez-Almeria M, et al. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. J Med Chem. 2022;doi: 10.1021/acs.jmedchem.1c01942.
Nozal, V., Martínez-González, L., Gomez-Almeria, M., Gonzalo-Consuegra, C., Santana, P., Chaikuad, A., Pérez-Cuevas, E., Knapp, S., Lietha, D., Ramírez, D., Petralla, S., Monti, B., Gil, C., Martín-Requero, A., Palomo, V., de Lago, E., & Martinez, A. (2022). TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. Journal of medicinal chemistry, . https://doi.org/10.1021/acs.jmedchem.1c01942
Nozal, Vanesa, et al. "TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy." Journal of medicinal chemistry vol. (2022). doi: https://doi.org/10.1021/acs.jmedchem.1c01942
Nozal V, Martínez-González L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, Pérez-Cuevas E, Knapp S, Lietha D, Ramírez D, Petralla S, Monti B, Gil C, Martín-Requero A, Palomo V, de Lago E, Martinez A. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. J Med Chem. 2022 Jan 03; doi: 10.1021/acs.jmedchem.1c01942. Epub 2022 Jan 03. PMID: 34978799.
Copy Download .nbib Format: NLM
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Poetto AS, Posocco B, Gagno S, Orleni M, Zanchetta M, Iacuzzi V, Canil G, Buzzo M, Montico M, Guardascione M, Basile D, Pelizzari G, Alberti M, Gerratana L, Puglisi F, Toffoli G.
PMID: 34700133
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122985. doi: 10.1016/j.jchromb.2021.122985. Epub 2021 Oct 11.

Therapeutic drug monitoring (TDM) is strongly suggested to define the proper drug dosage to overcome inter- and intra-patient variability in drug exposure, which is typically observed with oral anticancer agents, such as palbociclib (PALBO), ribociclib (RIBO) and letrozole (LETRO),...

Cite
Poetto AS, Posocco B, Gagno S, et al. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1185:122985doi: 10.1016/j.jchromb.2021.122985.
Poetto, A. S., Posocco, B., Gagno, S., Orleni, M., Zanchetta, M., Iacuzzi, V., Canil, G., Buzzo, M., Montico, M., Guardascione, M., Basile, D., Pelizzari, G., Alberti, M., Gerratana, L., Puglisi, F., & Toffoli, G. (2021). A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1185122985. https://doi.org/10.1016/j.jchromb.2021.122985
Poetto, Ariana Soledad, et al. "A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1185 (2021): 122985. doi: https://doi.org/10.1016/j.jchromb.2021.122985
Poetto AS, Posocco B, Gagno S, Orleni M, Zanchetta M, Iacuzzi V, Canil G, Buzzo M, Montico M, Guardascione M, Basile D, Pelizzari G, Alberti M, Gerratana L, Puglisi F, Toffoli G. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122985. doi: 10.1016/j.jchromb.2021.122985. Epub 2021 Oct 11. PMID: 34700133.
Copy Download .nbib Format: NLM
Responsiveness and minimal important change of the Pain Catastrophizing Scale in people with chronic low back pain undergoing multidisciplinary rehabilitation.

European journal of physical and rehabilitation medicine

Monticone M, Portoghese I, Rocca B, Giordano A, Campagna M, Franchignoni F.
PMID: 34042409
Eur J Phys Rehabil Med. 2021 May 27; doi: 10.23736/S1973-9087.21.06729-0. Epub 2021 May 27.

BACKGROUND: The Pain Catastrophizing Scale (PCS), a widely used tool to assess catastrophizing related to spinal disorders, shows valid psychometric properties in general but the minimal important change (MIC) is still not determined.DESIGN: Prospective observational study.AIM: To assess responsiveness...

Cite
Monticone M, Portoghese I, Rocca B, et al. Responsiveness and minimal important change of the Pain Catastrophizing Scale in people with chronic low back pain undergoing multidisciplinary rehabilitation. Eur J Phys Rehabil Med. 2021;doi: 10.23736/S1973-9087.21.06729-0.
Monticone, M., Portoghese, I., Rocca, B., Giordano, A., Campagna, M., & Franchignoni, F. (2021). Responsiveness and minimal important change of the Pain Catastrophizing Scale in people with chronic low back pain undergoing multidisciplinary rehabilitation. European journal of physical and rehabilitation medicine, . https://doi.org/10.23736/S1973-9087.21.06729-0
Monticone, Marco, et al. "Responsiveness and minimal important change of the Pain Catastrophizing Scale in people with chronic low back pain undergoing multidisciplinary rehabilitation." European journal of physical and rehabilitation medicine vol. (2021). doi: https://doi.org/10.23736/S1973-9087.21.06729-0
Monticone M, Portoghese I, Rocca B, Giordano A, Campagna M, Franchignoni F. Responsiveness and minimal important change of the Pain Catastrophizing Scale in people with chronic low back pain undergoing multidisciplinary rehabilitation. Eur J Phys Rehabil Med. 2021 May 27; doi: 10.23736/S1973-9087.21.06729-0. Epub 2021 May 27. PMID: 34042409.
Copy Download .nbib Format: NLM
[Giant hemangioma treated with interferon alpha-2a].

Jornal de pediatria

Silva CM, Viana MB, Gontijo B, Fernandes RA, Pereira LB.
PMID: 14685404
J Pediatr (Rio J). 1997 Jul-Aug;73(4):277-80. doi: 10.2223/jped.559.

OBJECTIVE: The authors describe a case of giant hemangioma treated with interferon alpha-2a and review the role of this drug and other therapeutic modalities in the management of vascular lesions.METHODS: A seven month-old child with giant hemangioma and persistent...

Cite
Silva CM, Viana MB, Gontijo B, et al. Hemangioma gigante tratado com Interferon Alfa-2a. [Giant hemangioma treated with interferon alpha-2a]. J Pediatr (Rio J). 1997;73(4):277-80doi: 10.2223/jped.559.
Silva, C. M., Viana, M. B., Gontijo, B., Fernandes, R. A., & Pereira, L. B. (1997). Hemangioma gigante tratado com Interferon Alfa-2a. [Giant hemangioma treated with interferon alpha-2a]. Jornal de pediatria, 73(4), 277-80. https://doi.org/10.2223/jped.559
Silva, C M, et al. "Hemangioma gigante tratado com Interferon Alfa-2a." [Giant hemangioma treated with interferon alpha-2a]. Jornal de pediatria vol. 73,4 (1997): 277-80. doi: https://doi.org/10.2223/jped.559
Silva CM, Viana MB, Gontijo B, Fernandes RA, Pereira LB. Hemangioma gigante tratado com Interferon Alfa-2a. [Giant hemangioma treated with interferon alpha-2a]. J Pediatr (Rio J). 1997 Jul-Aug;73(4):277-80. doi: 10.2223/jped.559. Portuguese. PMID: 14685404.
Copy Download .nbib Format: NLM
Innovative Digital Technologies for Purchasing and Consumption in Urban and Regional Agro-Food Systems: A Systematic Review.

Foods (Basel, Switzerland)

Samoggia A, Monticone F, Bertazzoli A.
PMID: 33498393
Foods. 2021 Jan 20;10(2). doi: 10.3390/foods10020208.

The use of digital technologies in the agro-food sector is growing worldwide, and applications in the urban and regional food systems represent a relevant segment of such growth. The present paper aims at reviewing the literature on which and...

Cite
Samoggia A, Monticone F, Bertazzoli A. Innovative Digital Technologies for Purchasing and Consumption in Urban and Regional Agro-Food Systems: A Systematic Review. Foods. 2021;10(2)doi: 10.3390/foods10020208.
Samoggia, A., Monticone, F., & Bertazzoli, A. (2021). Innovative Digital Technologies for Purchasing and Consumption in Urban and Regional Agro-Food Systems: A Systematic Review. Foods (Basel, Switzerland), 10(2), . https://doi.org/10.3390/foods10020208
Samoggia, Antonella, et al. "Innovative Digital Technologies for Purchasing and Consumption in Urban and Regional Agro-Food Systems: A Systematic Review." Foods (Basel, Switzerland) vol. 10,2 (2021). doi: https://doi.org/10.3390/foods10020208
Samoggia A, Monticone F, Bertazzoli A. Innovative Digital Technologies for Purchasing and Consumption in Urban and Regional Agro-Food Systems: A Systematic Review. Foods. 2021 Jan 20;10(2). doi: 10.3390/foods10020208. PMID: 33498393; PMCID: PMC7909407.
Copy Download .nbib Format: NLM
Luminescent Ln-Ionic Liquids beyond Europium.

Molecules (Basel, Switzerland)

Pereira CCL, Carretas JM, Monteiro B, Leal JP.
PMID: 34443420
Molecules. 2021 Aug 10;26(16). doi: 10.3390/molecules26164834.

Searching in the Web of Knowledge for "ionic liquids" AND "luminescence" AND "lanthanide", around 260 entries can be found, of which a considerable number refer solely or primarily to europium (90%, ~234). Europium has been deemed the best lanthanide...

Cite
Pereira CCL, Carretas JM, Monteiro B, et al. Luminescent Ln-Ionic Liquids beyond Europium. Molecules. 2021;26(16)doi: 10.3390/molecules26164834.
Pereira, C. C. L., Carretas, J. M., Monteiro, B., & Leal, J. P. (2021). Luminescent Ln-Ionic Liquids beyond Europium. Molecules (Basel, Switzerland), 26(16), . https://doi.org/10.3390/molecules26164834
Pereira, Cláudia C L, et al. "Luminescent Ln-Ionic Liquids beyond Europium." Molecules (Basel, Switzerland) vol. 26,16 (2021). doi: https://doi.org/10.3390/molecules26164834
Pereira CCL, Carretas JM, Monteiro B, Leal JP. Luminescent Ln-Ionic Liquids beyond Europium. Molecules. 2021 Aug 10;26(16). doi: 10.3390/molecules26164834. PMID: 34443420; PMCID: PMC8400174.
Copy Download .nbib Format: NLM
Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder.

Journal of substance abuse treatment

Monico LB, Ludwig A, Lertch E, Schwartz RP, Fishman M, Mitchell SG.
PMID: 34920900
J Subst Abuse Treat. 2021 Dec 12;108692. doi: 10.1016/j.jsat.2021.108692. Epub 2021 Dec 12.

INTRODUCTION: We know little about what youth with opioid use disorders (OUD) think about outpatient substance use treatment and 12-step meetings following discharge from residential substance use treatment. This study explores youths' preferences between intensive outpatient treatment (IOP) and...

Cite
Monico LB, Ludwig A, Lertch E, et al. Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder. J Subst Abuse Treat. 2021;108692doi: 10.1016/j.jsat.2021.108692.
Monico, L. B., Ludwig, A., Lertch, E., Schwartz, R. P., Fishman, M., & Mitchell, S. G. (2021). Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder. Journal of substance abuse treatment, 108692. https://doi.org/10.1016/j.jsat.2021.108692
Monico, Laura B, et al. "Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder." Journal of substance abuse treatment vol. (2021): 108692. doi: https://doi.org/10.1016/j.jsat.2021.108692
Monico LB, Ludwig A, Lertch E, Schwartz RP, Fishman M, Mitchell SG. Post-residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder. J Subst Abuse Treat. 2021 Dec 12;108692. doi: 10.1016/j.jsat.2021.108692. Epub 2021 Dec 12. PMID: 34920900.
Copy Download .nbib Format: NLM
Thrombin Generation Assay: Are We Ready for Prime Time?.

The journal of applied laboratory medicine

Pagano MB, Chandler WL.
PMID: 32630968
J Appl Lab Med. 2017 Sep 01;2(2):135-137. doi: 10.1373/jalm.2017.024083.

No abstract available.

Cite
Pagano MB, Chandler WL. Thrombin Generation Assay: Are We Ready for Prime Time?. J Appl Lab Med. 2017;2(2):135-137doi: 10.1373/jalm.2017.024083.
Pagano, M. B., & Chandler, W. L. (2017). Thrombin Generation Assay: Are We Ready for Prime Time?. The journal of applied laboratory medicine, 2(2), 135-137. https://doi.org/10.1373/jalm.2017.024083
Pagano, Monica B, and Chandler, Wayne L. "Thrombin Generation Assay: Are We Ready for Prime Time?." The journal of applied laboratory medicine vol. 2,2 (2017): 135-137. doi: https://doi.org/10.1373/jalm.2017.024083
Pagano MB, Chandler WL. Thrombin Generation Assay: Are We Ready for Prime Time?. J Appl Lab Med. 2017 Sep 01;2(2):135-137. doi: 10.1373/jalm.2017.024083. PMID: 32630968.
Copy Download .nbib Format: NLM
Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism".

The Journal of clinical endocrinology and metabolism

Monticone S, Veglio F, Mulatero P.
PMID: 34610098
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e896-e897. doi: 10.1210/clinem/dgab719.

No abstract available.

Cite
Monticone S, Veglio F, Mulatero P. Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism". J Clin Endocrinol Metab. 2022;107(2):e896-e897doi: 10.1210/clinem/dgab719.
Monticone, S., Veglio, F., & Mulatero, P. (2022). Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism". The Journal of clinical endocrinology and metabolism, 107(2), e896-e897. https://doi.org/10.1210/clinem/dgab719
Monticone, Silvia, et al. "Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism"." The Journal of clinical endocrinology and metabolism vol. 107,2 (2022): e896-e897. doi: https://doi.org/10.1210/clinem/dgab719
Monticone S, Veglio F, Mulatero P. Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism". J Clin Endocrinol Metab. 2022 Jan 18;107(2):e896-e897. doi: 10.1210/clinem/dgab719. PMID: 34610098.
Copy Download .nbib Format: NLM
Proinflammation, profibrosis, and arterial aging.

Aging medicine (Milton (N.S.W))

Wang M, Monticone RE, McGraw KR.
PMID: 33103036
Aging Med (Milton). 2020 Mar 18;3(3):159-168. doi: 10.1002/agm2.12099. eCollection 2020 Sep.

Aging is a major risk factor for quintessential cardiovascular diseases, which are closely related to arterial proinflammation. The age-related alterations of the amount, distribution, and properties of the collagen fibers, such as cross-links and degradation in the arterial wall,...

Cite
Wang M, Monticone RE, McGraw KR. Proinflammation, profibrosis, and arterial aging. Aging Med (Milton). 2020;3(3):159-168doi: 10.1002/agm2.12099.
Wang, M., Monticone, R. E., & McGraw, K. R. (2020). Proinflammation, profibrosis, and arterial aging. Aging medicine (Milton (N.S.W)), 3(3), 159-168. https://doi.org/10.1002/agm2.12099
Wang, Mingyi, et al. "Proinflammation, profibrosis, and arterial aging." Aging medicine (Milton (N.S.W)) vol. 3,3 (2020): 159-168. doi: https://doi.org/10.1002/agm2.12099
Wang M, Monticone RE, McGraw KR. Proinflammation, profibrosis, and arterial aging. Aging Med (Milton). 2020 Mar 18;3(3):159-168. doi: 10.1002/agm2.12099. eCollection 2020 Sep. PMID: 33103036; PMCID: PMC7574637.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 248 entries